Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Ivy Rx vs Valhalla Vitality

Ivy Rx
Graded #178

Higher grade

vs+3.1999999999999957
Valhalla Vitality
Graded #253

Lower grade

The verdict

Ivy Rx takes it — 66.8/100 to 63.6/100.

Ivy Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Telehealth provider offering tiered compounded semaglutide and tirzepatide programs.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueIvy Rx +26
62
36
Dose & formulationEven
64
64
Clinical oversightEven
82
82
Labs & monitoringValhalla Vitality +30
53
83
FulfillmentIvy Rx +14
81
67
Contract termsValhalla Vitality +6
55
61
Ivy Rx · left barValhalla Vitality · right bar

The numbers

MetricIvy RxValhalla Vitality
WeighScore66.8/10063.6/100
GradeCC
Scorecard rank#178#253
Semaglutide$175/mo (starting dose, compounded)$449/mo (compounded)
Tirzepatide$275/mo (starting dose, compounded)$449/mo (compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Ivy Rx

Graded #178 · C

Strengths

  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details
Valhalla Vitality

Graded #253 · C

Strengths

  • LegitScript-certified pharmacy partner
  • Offers both compounded semaglutide and tirzepatide
  • No membership fees and free consultations
  • Add-on peptide and hormone therapies plus at-home labs

Where it loses points

  • Compounded GLP-1 only, no FDA-approved branded options
  • Pricing not transparently listed on the main site
  • Compounded drugs are not FDA-approved for safety or efficacy
  • States served not clearly disclosed

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard